Clozapine Treatment for Cabergoline-Induced Psychosis in a Patient With a Giant Prolactinoma.

Autor: Pérez-Esparza R; From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O)., Rojas-Guerrero CA; From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O)., Andino-Rios GG; From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O)., Arias-Garro P; From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O)., Ramírez-Bermúdez J; From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O)., Portocarrero-Ortiz L; From the Department of Neuropsychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E, PA-G, JR-B); the Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (RP-E); and the Department of Neuroendocrinology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico (CAR-G, GGA-R, LP-O).

Publikováno v: The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] Summer 2017; Vol. 29 (3), pp. 295-297. Date of Electronic Publication: 2017 Feb 27.

Determining Ideal Management for Patients With Coexisting Prolactinomas and Psychiatric Symptoms: A Systematic Review.

Autor: Paracha, Awais, Durrani, Umar, Vasireddy, Satvik, Abid, Ali, Waheed, Fatima, Thomure, Michael

Publikováno v: Journal of Psychiatric Practice®; May2024, Vol. 30 Issue 3, p200-211, 12p

Start low, go slowly – mental abnormalities in young prolactinoma patients under cabergoline therapy.

Autor: Brichta, Corinna Melanie, Wurm, Michael, Krebs, Andreas, Schwab, Karl Otfried, van der Werf-Grohmann, Natascha

Publikováno v: Journal of Pediatric Endocrinology & Metabolism; Sep2019, Vol. 32 Issue 9, p969-977, 9p

Prolactin Disorders : From Basic Science to Clinical Management

Autor: Nicholas A. Tritos, Anne Klibanski

This unique book will serve as a valuable resource for clinicians and researchers interested in prolactin physiology and pathophysiology and those who are involved in the care of patients with related disorders, including hyperprolactinemia and prola